Scientific Leadership & Editorial Board
Operating as the B2B life sciences and laboratory media division of Jayanti Cybernetics, BioScienceDesk is led by industry veterans, biotech founders, and diagnostic scientists committed to publishing reproducible wet-lab protocols and unbiased instrumentation evaluations.
Executive Leadership & Scientific Review Board
Rahul Kumar
Founder & Chief Editorial Director
Seasoned life sciences executive leading commercial strategy, recombinant biologics (antigens, antibodies, cytokines), and diagnostic assay scale-up across diagnostic kit manufacturing, clinical lab operations, and biopharma partnerships.
Dr. S Paul
Chief Scientific Reviewer (Biologics & Immunology)
Ph.D. in Vaccine Development & Pathogenic Diagnostics from Defence Food Research Laboratory (DFRL / DRDO). Over 11 years leading recombinant vaccine platforms, carrier-free antigen engineering, and bioprocess R&D as Founder & MD of Pentavalent Bio Sciences.
Swatilina Das
Principal Diagnostic & Biosensor Reviewer
Biotech entrepreneur and biosensor specialist with an M.Sc. in Microbiology & Cellular Genetics from Indian Academy of Sciences and PG Diploma in Cellular & Molecular Diagnostics (Mount Carmel College). Founder & MD of B Cell Biologics and former Pentavalent scientist developing antibody-based biosensing & electrochemical point-of-care devices.
Our Mission & Editorial Rigor
In life sciences and clinical diagnostic development, reproducibility is the cornerstone of scientific progress. However, academic protocols often lack the practical troubleshooting steps, buffer compositions, and instrument settings required to translate bench assays into validated commercial products.
BioScienceDesk bridges this critical gap. Our editors and contributors are practicing biochemists, diagnostic founders, and assay engineers who rigorously vet every standard operating procedure (SOP), comparison matrix, and technical guide we publish.
Peer-Level Review
Every protocol undergoes secondary technical verification by subject-matter specialists.
Vendor Independence
Hardware benchmarks and reagent assessments are strictly separated from commercial relationships.
Editorial Ethics
Adherence to international research integrity, conflict-of-interest transparency, and errata standards.
Regulatory Context
Evaluation protocols benchmarked against CLSI EP guidelines, ISO 13485, and CE-IVDR dossiers.
Specialized Technical Review Desks
Six dedicated editorial verticals ensuring domain-specific precision across the life sciences.
Molecular Diagnostics & IVD Desk
Assay Verification & Point-of-Care Testing
Evaluates lateral flow troubleshooting, qPCR fluorophore multiplexing, analytical Limit of Detection (LoD) protocols, and IVD validation frameworks.
Genomics & Precision Oncology Desk
High-Throughput Sequencing & Translational Trials
Oversees hybrid-capture NGS workflows, targeted variant alignment, bispecific antibody mechanisms, and FDA clinical trial endpoint verification.
Upstream Bioprocessing & CDMO Desk
Industrial Scale-Up & Manufacturing SOPs
Dedicated to upstream CHO cell bioreactor optimization, fed-batch yield metrics, downstream Protein A affinity chromatography, and cleanroom SOPs.
Immunology & Recombinant Reagents Desk
Biomarker & Reagent Standards
Oversees antibody validation, polyclonal/monoclonal specificity testing, cross-reactivity profiling, and ELISA background passivation methods.
Capital Equipment & Core Facilities Desk
Instrumentation Metrology & Benchmarks
Publishes standardized comparative evaluations of spectral flow cytometers, automated liquid handlers, mass spectrometers, and ISO 8655 pipette calibration.
Regulatory Compliance & Quality Standards Desk
CE-IVDR, CLSI & ISO Quality Systems
Analyzes analytical and clinical performance protocols under EU IVDR 2017/746, CLSI evaluation protocols (EP05, EP06, EP17), and ISO 13485 requirements.
Corporate Ownership & Intellectual Property
BioScienceDesk is published and operated as an independent scientific editorial division of Jayanti Cybernetics (Dun & Bradstreet D-U-N-S® Verified Entity).
All proprietary benchmark matrices, sequencing comparative models, electropherogram interpretation SOPs, and original technical articles published across BioScienceDesk are the exclusive Intellectual Property of Jayanti Cybernetics. Protected under the Indian Copyright Act, 1957, DMCA, and international intellectual property conventions.